BRCA 1 & 2, ATM, CDH1, CHEK2, MRE11A, MSH6, NBN, p53, PALB2, PMS2, PTEN, RAD50, RECQL, and RINT1 genes
Posted on: Mar 9, 2018 12:47PM
FDA Authorizes 23andMe BRCA Genetic Test, but Test Only IDs Three Mutations
March 7, 2018
The FDA has authorized a direct-to-consumer test to identify BRCA mutations, but it's important to know that the test only looks for three mutations that are extremely rare in the general population. Read more...